Showing results (141-150 of 215) with videos related to
Sort By:
Pageof 22
Neurology|February 26, 2016
Neuroinflammation in treated HIV-positive individuals: A TSPO PET studyJaime H Vera, Qi Guo, James H Cole, et al.AIDS (London, England)|December 30, 2025
Associations between plasma biomarkers and changes in cognitive function over two years in people with and without HIVJasmini Alagaratnam, Nicholas Bakewell, Ken M Kunisaki, et al.The Lancet. HIV|September 16, 2024
Cognitive performance, neuropsychiatric symptoms, and cerebrospinal fluid viral control following programmatic switch from efavirenz-based to dolutegravir-based antiretroviral therapy in South Africa (CONNECT): a prospective cohort studySam Nightingale, Anna J Dreyer, Kevin G F Thomas, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 21, 2022
The clinical presentation of monkeypox: a retrospective case-control study of patients with possible or probable monkeypox in a West London cohortStephanie Rimmer, James Barnacle, Malick M Gibani, et al.AIDS (London, England)|July 2, 2019
Risk factors and impact of patterns of co-occurring comorbidities in people living with HIVDavide De Francesco, Jonathan Underwood, Emmanouil Bagkeris, et al.Plos One|May 7, 2013
Neurocognitive function in HIV infected patients on antiretroviral therapyAlan Winston, Alejandro Arenas-Pinto, Wolfgang Stöhr, et al.HIV Medicine|April 16, 2026
Longitudinal changes in plasma biomarkers of immune activation, neuronal inflammation and injury in persons with HIV initiating ARTMerle Henderson, Peter Dutey-Magni, Carolina Herrera, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 27, 2020
Associations Between Widespread Pain and Sleep Quality in People With HIVCaroline A Sabin, Richard Harding, Nicki Doyle, et al.Elife|August 13, 2021
Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapyAlexander O Pasternak, Jelmer Vroom, Neeltje A Kootstra, et al.Eclinicalmedicine|February 16, 2024
Long-term efficacy and safety of a treatment strategy for HIV infection using protease inhibitor monotherapy: 8-year routine clinical care follow-up from a randomised, controlled, open-label pragmatic trial (PIVOT)Nicholas I Paton, Wolfgang Stöhr, Alejandro Arenas-Pinto, et al.Pageof 22